- Screening Matters Newsletter
The National Screening Unit newsletter
In this issue:
- Training for DHB staff on new newborn hearing screening equipment and protocols
- E-colposcopy now live in seven DHBs
- The importance of timely newborn metabolic screening
- Maternal weight’s role in risk calculation for Down syndrome and other conditions
- Two new NCSP appointments
- Changes underway for antenatal HIV screening
- Gathering good quality ethnicity data
- New senior portfolio manager for BreastScreen Aotearoa
Changes underway for antenatal HIV screening
Antenatal HIV screening, along with five other blood tests, will continue to be offered to all pregnant women as a routine part of their antenatal care. Antenatal HIV screening was introduced in 2008 after a child acquired HIV through perinatal transmission and the mother had not been offered testing.
The aim of the antenatal HIV screening programme is to identify pregnant women with HIV so they can be given treatment which will reduce the likelihood of HIV being transmitted to their baby before it is born or during labour and birth. Diagnosis and appropriate treatment of women with HIV in pregnancy reduces the chance of perinatal transmission of the virus from 31.5 percent to less than 1 percent.
If testing shows a reactive or positive result, the screening laboratory will provide practitioners with guidance on the next steps.
The NSU practitioner procedures and guidelines can also assist, along with DHB infectious disease teams. The NSU will continue to make consumer resources available.
To receive the Screening Matters newsletter by email, fill out our sign-up form.